A spatial modelling method for vector surveillance
Vector borne diseases are a specific group of infectious diseases that are a (re-)emerging threat to Europe.
One important aspect of preparedness for vector borne diseases is the surveillance of the introduction, establishment and spread of the main disease vectors. ECDC regularly publishes updated vector distribution maps at the NUTS3 level.
This document describes a methodology to estimate the vector distribution status for those NUTS3 units for which observations are not yet available . These estimates are produced with spatial modelling techniques, using the currently available distributions to calibrate the modelling process. This document provides an overview of gap analysis procedures, sets out the full methodology, and also provide s details of which methodological components were used with each output provided.
Smallpox - Annual Epidemiological Report for 2018
Smallpox was declared eradicated in 1980. There were no reports of confirmed or possible smallpox in the EU/EEA or other countries for 2018.
Report of the third independent external evaluation of the ECDC
The third external evaluation of the European Centre for Disease Prevention and Control (ECDC) was initiated in 2018. The primary objective of the evaluation is to assess the extent to which the Centre has carried out its missions and tasks over the period 2013‐2017. The second objective of the evaluation is to assess the need to extend the scope of the Centre’s mission to other relevant EU-level activities in the field of public health, and whether its current structure and organisation can support the integration of new tasks.
Tularaemia Annual Epidemiological Report for 2018
For 2018, 18 countries in the EU/EEA reported 441 cases of tularaemia, 358 (81%) of which were confirmed. The EU/EEA notification rate for 2018 was 0.07 cases per 100 000 population. The male-to-female ratio was 1.7:1. As in previous years, the notification rate among males was higher in most age groups except for the age groups between 5 and 24 years. Notification rates increased with age and peaked at 45–64 years.
Monthly measles and rubella monitoring report, November 2019
The monitoring report is based on measles and rubella data from The European Surveillance System (TESSy) for 1 October 2018 to 30 September 2019. Twenty-nine countries reported measles data for September 2019, of which 280 cases were reported by 17 countries; 12 countries reported no cases. Overall, case numbers continued to decrease compared with the previous two months. Romania and France had the highest case counts with 112 and 56 cases, respectively. Notable decreases were reported in France, Italy, the United Kingdom and Lithuania.
Influenza virus characterisation, October 2019
This is the first report for the 2019–20 influenza season. As of week 44/2019, 1 138 influenza detections across the WHO European Region had been reported; 80% type A viruses, with A(H3N2) prevailing over A(H1N1)pdm09, and 20% type B viruses, with 26 of 27 (96%) ascribed to a lineage being B/Victoria.
Communicable Disease Threats Report, 3-9 November 2019, Week 45
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 3-9 November 2019 and includes updates on Ebola virus disease, measles, mass gathering monitoring (Japan, Rugby World Cup 2019), Dengue,, poliomyelitis, influenza and West Nile virus.
Congenital toxoplasmosis - Annual Epidemiological Report for 2017
In 2017, 194 confirmed cases of congenital toxoplasmosis were reported in the EU/EEA, with France accounting for 79% of all confirmed cases due to active screening of pregnant women. The overall notification rate was 5.3 cases per 100 000 live births. No seasonal pattern was observed for the disease.
Yersiniosis - Annual Epidemiological Report for 2018
For 2018, 29 countries reported 7 204 confirmed yersiniosis cases in the EU/EEA. The overall notification rate was 1.7 per 100 000 population and remained stable from 2014 to 2018. The highest rates were reported by Finland, Belgium and the Czech Republic. The highest rate was detected in 0-4 year-old children; 7.9 per 100 000 population for males and 6.8 per 100 000 population for females.